VIGILINT

GLOBAL PROTECTION. DEDICATED CARE.

global protection. dedicated care.

              24/7 telemedicine.      logistics.       medical advisory solutions. 

Travel MedAssist Program
Global MedAssist Program

The Vigilint Advantage: Patient to Doctor in 30 seconds

Seconds
IN THE NEWS 

May 14, 2020: In an interview with The Washington Post FedEx CEO Frederick W. Smith credits the company's long-term medical advisory company, VIGILINT, for early COVID-19 containment strategies. Dr. Eric Ossmann advised FedEx immediately upon discovery of the virus in Wuhan, China in January 2020. 

Intelligence-driven, global protection

Interactive Worldwide Health Risk Map - Updated on an Ongoing Basis

On March 31, 2020, the U.S State Department issued a Global Level 4 Health Advisory - DO NOT TRAVEL. All US citizens should avoid international travel due to the global impact of COVID-19. 

Countries experiencing a significant strain in their public healthcare systems due to COVID-19 cases, and countries with additional travel advisories unrelated to COVID-19 from the US State Department and the CDC, have been identified in the map below. 

hover over any country for THE LATEST TRAVEL ADVISORIES, INFECTIOUS DISEASE WARNINGS, and proprietary healthcare infrastructure intel.

 

Front Page Placeholder
Front Page

Medical Risk

High

Medium

Low

Neutral

The Vigilint Blog

COVID-19 ONE YEAR LATER, Part II: Testing and Vaccines

By Colin Schilly | February 12, 2021

In the second part of VIGILINT’s two-part series COVID-19 1 Year Later, VIGILINT Ops Analyst and blogger Colin Schilly dives into the two critical hallmarks of the pandemic. Testing and vaccines. The development and rollout of several effective vaccines in under a year offer great hope for the pandemic’s end. Sadly, that day may still… Read more about COVID-19 ONE YEAR LATER, Part II: Testing and Vaccines

COVID-19 ONE YEAR LATER, Part I: The Best and Worst Handlings of the COVID-19 Crisis

By Emily Elmore | February 4, 2021

On January 10, 2020, VIGILINT first reported a new strain of a coronavirus connected to a cluster of pneumonia cases linked to Wuhan, China. No one could have predicted the year that would follow. As of publishing, worldwide cases have reached 104 million with 2.27 million deaths. VIGILINT looks back at the critical events that… Read more about COVID-19 ONE YEAR LATER, Part I: The Best and Worst Handlings of the COVID-19 Crisis

COVID-19 Transmission: Surfaces

By Alex Snyder | January 27, 2021

There is some risk of COVID-19 transmission from surfaces, but the primary disease transfer mode is airborne transmission. Several studies have analyzed the detection of COVID-19 on various surfaces. One such study, published by the New England Journal of Medicine in March 2020, largely shaped the discussion around SARS-COV-2 (the virus causing COVID-19 disease) transmissions… Read more about COVID-19 Transmission: Surfaces

COVID-19 Update: Vaccine Distribution

By Nick Debo | January 15, 2021

The Trump administration is reversing its COVID-19 vaccination strategy by authorizing the release of Pfizer-BioNtech and Moderna’s federally stockpiled vaccines. The previous policy withheld half the purchased doses to ensure the supply necessary for second doses, and states could only receive vaccines based on their adult population size. The new distribution strategy unveiled yesterday is intended… Read more about COVID-19 Update: Vaccine Distribution

VIGILINT Travel Notice: COVID-19 Testing for International Flights to the United States

By Intel & Marketing | January 14, 2021

COVID-19 TESTING FOR INTERNATIONAL FLIGHTS TO THE UNITED STATES 14 January 2021

COVID-19 VACCINE FACT SHEET

By Emily Elmore | January 13, 2021

COVID-19 VACCINES FAQ JAN13

Real Physicians. Real Experience. Real-time Support.

During a recent trip to Hanoi, Vietnam, Tara's minor strep throat progressed to a severe one-in-a-million case and almost cost her her life. Tara and her travel companion discuss the terrifying ordeal and how VIGILINT and Cleveland Clinic's GMAP program saved her life.

Sign up for our Monthly Newsletter

Featuring global health news from our Medical Intelligence Center

Sign Up!

"As a global media and communications company, complex medical challenges frequently confront our offices and business travelers. VIGILINT plays a valuable role in our crisis management process as a trusted medical advisor. Their team is incredibly knowledgeable and responsive. Global companies like ours are constantly affected by international health issues and VIGILINT has been a true partner when we needed an informed opinion to help set policy and guidance with respect to medical challenges affecting the health and safety of our employees and our ability to meet our client obligations. They are my first call whenever a medical crisis arises.”

-Director of Business Continuity & Crisis Management, Fortune 500 global advertising and marketing services company

"We have been using VIGILINT for the past two years and have been very satisfied with their services. The information and services have been provided in a very timely manner with extremely accurate information. They have been an intricate part in our planning of large corporate events."

-Manager of Risk Services, $10-billion-a-year consumer products company

“Simply put, VIGILINT is unmatched anywhere. They are compassionate, with high professional standards and an unwavering commitment to their client. For many years, VIGILINT has allowed our Family Office to travel with confidence, with complicated medical problems. This is the most complete, impressive, full-service program I have ever encountered. They are highly respected physicians who believe in personalized service.”

-West Coast family office (family-owned global event production company)